G. Maartens, C. Celum, and S. R. Lewin, HIV infection: epidemiology, pathogenesis, treatment, and prevention, Lancet, vol.384, pp.258-71, 2014.
DOI : 10.1016/s0140-6736(14)60164-1

F. Barr-e-sinoussi, A. L. Ross, and J. Delfraissy, Past, present and future: 30 years of HIV research, Nat Rev Microbiol, vol.11, pp.877-83, 2013.

C. Katlama, S. G. Deeks, B. Autran, J. Martinez-picado, J. Van-lunzen et al., Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs, Lancet, vol.381, pp.2109-2126, 2013.
DOI : 10.1016/s0140-6736(13)60104-x
URL : http://europepmc.org/articles/pmc3815451?pdf=render

M. J. Churchill, S. G. Deeks, D. M. Margolis, R. F. Siliciano, and R. Swanstrom, HIV reservoirs: what, where and how to target them, Nat Rev Microbiol, vol.14, pp.55-60, 2016.
DOI : 10.1038/nrmicro.2015.5

C. Deleage, S. W. Wietgrefe, D. Prete, G. Morcock, D. R. Hao et al., Defining HIV and SIV reservoirs in lymphoid tissues, Pathog Immun, vol.1, pp.68-106, 2016.
DOI : 10.20411/pai.v1i1.100
URL : https://paijournal.com/index.php/paijournal/article/download/100/44

I. Sereti, S. J. Krebs, N. Phanuphak, J. L. Fletcher, B. Slike et al., Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection, Clin Infect Dis, vol.64, pp.124-155, 2017.
DOI : 10.1093/cid/ciw683
URL : https://academic.oup.com/cid/article-pdf/64/2/124/8959361/ciw683.pdf

D. R. Boulware, K. H. Hullsiek, C. E. Puronen, A. Rupert, J. V. Baker et al., Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death, J Infect Dis, vol.203, pp.1637-1683, 2011.

M. A. French, M. S. King, J. M. Tschampa, B. A. Da-silva, and A. L. Landay, Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells, J Infect Dis, vol.200, pp.1212-1217, 2009.

P. W. Hunt, J. Brenchley, E. Sinclair, J. M. Mccune, M. Roland et al., Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy, J Infect Dis, vol.197, pp.126-159, 2008.

N. Noel, F. Boufassa, C. Saez-cirion, A. Bourgeois, C. Dunyachremy et al., Elevated IP10 levels are associated with immune activation and low CD4 + T-cell counts in HIV controller patients, AIDS, vol.28, pp.467-76, 2014.
DOI : 10.1097/qad.0000000000000174
URL : https://hal.archives-ouvertes.fr/pasteur-01420524

S. Krishnan, E. Wilson, V. Sheikh, A. Rupert, D. Mendoza et al., Evidence for innate immune system activation in HIV type 1-infected elite controllers, J Infect Dis, vol.209, pp.931-940, 2014.
DOI : 10.1093/infdis/jit581
URL : https://academic.oup.com/jid/article-pdf/209/6/931/17410130/jit581.pdf

A. H. Borges, M. J. Silverberg, D. Wentworth, A. E. Grulich, G. Mitsuyasu et al., Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers, AIDS, vol.27, pp.1433-1474, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01101192

A. D. Nordell, M. Mckenna, A. H. Borges, D. Duprez, J. Neuhaus et al., Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation, J Am Heart Assoc, vol.3, p.844, 2014.

J. D. Siliciano and R. F. Siliciano, Recent developments in the effort to cure HIV infection: going beyond N = 1, J Clin Invest, vol.126, pp.409-423, 2016.

S. R. Lewin, S. G. Deeks, and F. Barr-e-sinoussi, Towards a cure for HIV-are we making progress?, Lancet, vol.384, pp.209-220, 2014.
DOI : 10.1016/s0140-6736(14)61181-8

M. Paiardini and M. M?-uller-trutwin, HIV-associated chronic immune activation, Immunol Rev, vol.254, pp.78-101, 2013.
DOI : 10.1111/imr.12079
URL : http://europepmc.org/articles/pmc3729961?pdf=render

A. S. Zevin, L. Mckinnon, A. Burgener, and N. R. Klatt, Microbial translocation and microbiome dysbiosis in HIV-associated immune activation, Curr Opin HIV AIDS, vol.11, pp.182-90, 2016.
DOI : 10.1097/coh.0000000000000234
URL : http://europepmc.org/articles/pmc4752849?pdf=render

J. M. Brenchley, D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri et al., Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nat Med, vol.12, pp.1365-71, 2006.

A. Schuetz, C. Deleage, I. Sereti, R. Rerknimitr, N. Phanuphak et al., Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation, PLoS Pathog, vol.10, p.1004543, 2014.

C. Deleage, A. Schuetz, W. G. Alvord, L. Johnston, X. Hao et al., Impact of early cART in the gut during acute HIV infection, JCI Insight, vol.1, p.87065, 2016.

J. C. Mudd and J. M. Brenchley, Gut mucosal barrier dysfunction, microbial dysbiosis, and their Role in HIV-1 disease progression, J Infect Dis, vol.214, issue.2, pp.58-66, 2016.
DOI : 10.1093/infdis/jiw258
URL : https://academic.oup.com/jid/article-pdf/214/suppl_2/S58/7076803/jiw258.pdf

M. Somsouk, R. M. Dunham, M. Cohen, R. Albright, M. Abdel-mohsen et al., The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial, PLoS ONE, vol.9, p.116306, 2014.

J. Kristoff, G. Haret-richter, D. Ma, R. M. Ribeiro, C. Xu et al., Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication, J Clin Invest, vol.124, pp.2802-2808, 2014.
DOI : 10.1172/jci75090
URL : http://www.jci.org/articles/view/75090/files/pdf

N. G. Sandler, X. Zhang, R. J. Bosch, N. T. Funderburg, A. I. Choi et al., Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection, J Infect Dis, vol.210, pp.1549-54, 2014.
DOI : 10.1093/infdis/jiu305
URL : https://academic.oup.com/jid/article-pdf/210/10/1549/18070500/jiu305.pdf

A. R. Tenorio, E. S. Chan, R. J. Bosch, B. Macatangay, S. W. Read et al., Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapyACTG A5286, J Infect Dis, vol.211, pp.780-90, 2015.
DOI : 10.1093/infdis/jiu515
URL : https://academic.oup.com/jid/article-pdf/211/5/780/16867097/jiu515.pdf

J. A. Manuzak, T. Hensley-mcbain, A. S. Zevin, C. Miller, R. Cubas et al., Enhancement of microbiota in healthy macaques results in beneficial modulation of mucosal and systemic immune function, J Immunol, vol.196, pp.2401-2410, 2016.

T. Hensley-mcbain, A. S. Zevin, J. Manuzak, E. Smith, J. Gile et al., Effects of fecal microbial transplantation on microbiome and immunity in simian immunodeficiency virus-infected macaques, J Virol, vol.90, pp.4981-4990, 2016.

A. M. Ortiz, Z. A. Klase, S. R. Dinapoli, I. Vujkovic-cvijin, K. Carmack et al., IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques, Mucosal Immunol, vol.9, pp.458-67, 2016.
DOI : 10.1038/mi.2015.75
URL : http://europepmc.org/articles/pmc4760912?pdf=render

G. Ettorre, G. Ceccarelli, N. Giustini, S. Serafino, N. Calantone et al., Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the "Probio-HIV" clinical trial, J Clin Invest, vol.10, pp.903-910, 2013.

S. Pallikkuth, L. Micci, Z. S. Ende, R. I. Iriele, B. Cervasi et al., Maintenance of intestinal Th17 cells and reduced microbial translocation in SIVinfected rhesus macaques treated with interleukin (IL)-21, PLoS Pathog, vol.9, p.1003471, 2013.

M. F. Chevalier, G. Petitjean, C. Dunyach-r-emy, C. Didier, P. Girard et al., The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation, PLoS Pathog, vol.9, p.1003453, 2013.

G. Marchetti, A. Cozzi-lepri, E. Merlini, G. M. Bellistr-i, A. Castagna et al., Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count, AIDS, vol.25, pp.1385-94, 2011.
DOI : 10.1097/qad.0b013e3283471d10

A. Le-on, L. Leal, B. Torres, C. Lucero, A. Inciarte et al., Association of microbial translocation biomarkers with clinical outcome in controllers HIVinfected patients, AIDS, vol.29, pp.675-81, 2015.

M. Abad-fern-andez, A. Vallejo, B. Hern-andez-novoa, C. Guti-errez, and N. Madrid, Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals, J Acquir Immune Defic Syndr, vol.2013, issue.64, pp.5438-5485, 1999.

K. Ohnuma, N. H. Dang, and C. Morimoto, Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function, Trends Immunol, vol.29, pp.295-301, 2008.
DOI : 10.1016/j.it.2008.02.010

A. Casrouge, J. Decalf, M. Ahloulay, C. Lababidi, H. Mansour et al., Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV, J Clin Invest, vol.121, pp.308-325, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01402089

A. De-pasquale, L. Ginaldi, P. Limoncelli, and D. Quaglino, Dipeptidyl amino peptidase IV cytochemistry in circulating lymphocytes from HIV-I-seropositive subjects, Acta Haematol, vol.81, pp.19-21, 1989.

M. J. Ploquin, Journal of the International AIDS Society, vol.21, 2018.

M. V. Blazquez, J. A. Madue~-no, R. Gonzalez, R. Jurado, W. W. Bachovchin et al., Selective decrease of CD26 expression in T cells from HIV-1-infected individuals, J Immunol, vol.149, pp.3073-3080, 1992.

G. Vanham, L. Kestens, D. Meester, I. Vingerhoets, J. Penne et al., Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects, J Acquir Immune Defic Syndr, vol.6, pp.749-57, 1993.

M. L. Gougeon, H. Lecoeur, C. Callebaut, E. Jacotot, A. Dulioust et al., Selective loss of the CD4+/CD26+ T-cell subset during HIV infection, Res Immunol, vol.147, pp.5-8, 1996.

O. Hosono, T. Homma, H. Kobayashi, Y. Munakata, Y. Nojima et al., Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals, Clin Immunol, vol.91, pp.283-95, 1999.

M. J. Ploquin, Y. Madec, A. Casrouge, N. Huot, C. Passaes et al., Elevated basal pre-infection CXCL10 in plasma and in the small intestine after infection are associated with more rapid HIV/SIV disease onset, PLoS Pathog, vol.12, p.1005774, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01380604

Z. Euler, M. J. Van-gils, B. D. Boeser-nunnink, H. Schuitemaker, and D. Van-manen,

, Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals, PLoS ONE, vol.8, p.54684, 2013.

F. Boufassa, C. Goujard, J. Viard, R. Carlier, B. Lefebvre et al., Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort, Antivir Ther, vol.17, pp.91-100, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00848065

M. Ghislain, J. Bastard, L. Meyer, J. Capeau, S. Fellahi et al., Late antiretroviral therapy (ART) initiation is associated with long-term persistence of systemic inflammation and metabolic abnormalities, PLoS ONE, vol.10, p.144317, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01277861

A. Liovat, C. Rey-cuill-e-m-a,-l-ecuroux, J. B. Girault, I. Petitjean, and G. , Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection, PLoS ONE, vol.7, p.46143, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01968867

J. Ghosn, I. Pellegrin, C. Goujard, C. Deveau, J. Viard et al., HIV1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time, AIDS, vol.20, pp.159-70, 2006.

C. Goujard, M. Bonarek, L. Meyer, F. Bonnet, M. Chaix et al., CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients, Clin Infect Dis, vol.42, pp.709-724, 2006.

M. Laanani, J. Ghosn, A. Essat, A. Melard, R. Seng et al., Impact of the timing of initiation of antiretroviral therapy during primary HIV-1 infection on the decay of cell-associated HIV-DNA, Clin Infect Dis, vol.60, pp.1715-1736, 2015.

N. Ngo-giang-huong, C. Deveau, D. Silva, I. Pellegrin, I. Venet et al., Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy, AIDS, vol.15, pp.665-73, 2001.

O. M. Diop, A. Gueye, M. Dias-tavares, C. Kornfeld, F. A. Ave et al., High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys, J Virol, vol.74, pp.7538-7585, 2000.

B. Jacquelin, G. Petitjean, D. Kunkel, A. Liovat, S. P. Jochems et al., Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection, PLoS Pathog, vol.10, p.1004241, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01960800

I. Pandrea, C. Kornfeld, M. Ploquin, C. Apetrei, A. Faye et al., Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys, J Virol, vol.79, pp.6249-59, 2005.

M. Tejera-alhambra, A. Casrouge, C. De-andr-es, R. Ramos-medina, A. B. Vega et al., Low DPP4 expression and activity in multiple sclerosis, Clin Immunol, vol.150, pp.170-83, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-01384544

E. G. Meissner, J. Decalf, A. Casrouge, H. Masur, S. Kottilil et al., Dynamic changes of post-translationally modified forms of CXCL10 and soluble DPP4 in HCV subjects receiving interferon-free therapy, PLoS ONE, vol.10, p.133236, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01380964

C. Kornfeld, M. Ploquin, I. Pandrea, A. Faye, R. Onanga et al., Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS, J Clin Invest, vol.115, pp.1082-91, 2005.

B. Jacquelin, V. Mayau, B. Targat, A. Liovat, D. Kunkel et al., Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection, J Clin Invest, vol.119, p.56991, 2009.

P. Liang, B. Yeh, W. Li, T. Chan, C. Huang et al.,

, DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness, Oncotarget, vol.8, pp.2995-3008, 2017.

D. Kurktschiev, T. Temelkova-kurktschiev, K. Horn, and K. Schentke, Successful immunomodulating in AIDS patients with ursodeoxycholic acid-a pilot study, Clin Exp Immunol, vol.115, pp.144-150, 1999.

T. Garcia-tellez, N. Huot, M. J. Ploquin, P. Rascle, J. B. M?-uller-trutwin et al., Non-human primates in HIV research: achievements, limits and alternatives, Infect Genet Evol, vol.46, pp.324-356, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01419521

N. Huot, J. B. Garcia-tellez, T. Rascle, P. Ploquin, M. J. Madec et al., Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys, Nat Med, vol.23, pp.1277-86, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01984650

A. M. Mowat and W. W. Agace, Regional specialization within the intestinal immune system, Nat Rev Immunol, vol.14, pp.667-85, 2014.

L. Micci, E. S. Ryan, R. Fromentin, S. E. Bosinger, J. L. Harper et al., Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIVinfected macaques, J Clin Invest, vol.125, pp.4497-513, 2015.

S. A. Lee, Y. R. Kim, E. J. Yang, E. Kwon, S. H. Kim et al., CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus, J Clin Endocrinol Metab, vol.98, pp.2553-61, 2013.

T. Zheng, Y. Gao, A. Baskota, T. Chen, X. Ran et al., Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study, J Clin Endocrinol Metab, vol.99, pp.2330-2334, 2014.

M. Grujic, I. Z. Matic, M. D. Crnogorac, A. D. Velickovic, B. Kolundzija et al., Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs na? ?ve rheumatoid arthritis, Clin Chem Lab Med, vol.55, pp.73-81, 2017.

B. A. Stecca, B. Nardo, P. Chieco, A. Mazziotti, L. Bolondi et al., Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma, J Hepatol, vol.27, pp.337-382, 1997.

S. Molica, G. Digiesi, R. Mirabelli, G. Cutrona, A. Antenucci et al., Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia, Eur J Haematol, vol.83, pp.208-222, 2009.

D. J. Drucker and M. A. Nauck, The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes, Lancet, vol.368, pp.1696-705, 2006.

R. Barreira-da-silva, M. E. Laird, N. Yatim, L. Fiette, M. A. Ingersoll et al., Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy, Nat Immunol, vol.16, pp.850-858, 2015.
URL : https://hal.archives-ouvertes.fr/pasteur-01380810

D. Ragab, M. Laird, D. Duffy, A. Casrouge, R. Mamdouh et al., CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients, Cytokine, vol.63, pp.105-117, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01385516

P. K. Sharma, E. B. Wong, R. J. Napier, W. R. Bishai, T. Ndung'u et al., High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells, Immunology, vol.145, pp.443-53, 2015.

E. M. Songok, B. Osero, L. Mckinnon, M. K. Rono, W. Apidi et al.,

E. M. Songok, M. Luo, B. Liang, P. Mclaren, N. Kaefer et al., Saez-Cirion A, Jacquelin B, Barr e-Sinoussi F, M? uller-Trutwin M. Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure, CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers, vol.7, pp.1167-70, 1996.

M. J. Ploquin, Journal of the International AIDS Society, vol.21, 2018.